Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
New epilepsy therapies in development
2024 Standout
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
2022 Standout
Works of Ewa Sawicka being referenced
Intrathecal Infusion of Autologous Adipose-Derived Regenerative Cells in Autoimmune Refractory Epilepsy: Evaluation of Safety and Efficacy
2020
Infantile and juvenile spinal muscular atrophy
1968
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ewa Sawicka | 78 | 173 | 126 | 107 | 50 | 490 | |
| V. Forin | 158 | 99 | 72 | 116 | 36 | 502 | |
| K. Matsumoto | 104 | 95 | 58 | 44 | 46 | 428 | |
| Volker Schick | 126 | 111 | 74 | 34 | 39 | 557 | |
| Eun Young Park | 99 | 169 | 117 | 23 | 45 | 549 | |
| Takeo Mukai | 71 | 105 | 25 | 170 | 38 | 441 | |
| Robert Carlier | 78 | 88 | 42 | 141 | 28 | 444 | |
| Won Ah Choi | 101 | 170 | 19 | 90 | 50 | 424 | |
| Todd D. Nebesio | 66 | 74 | 109 | 35 | 34 | 570 | |
| R. Bauer | 87 | 76 | 44 | 50 | 32 | 431 | |
| Eva Fallentin | 120 | 54 | 55 | 24 | 35 | 534 |
All Works
Login with ORCID to disown or claim papers
Loading papers...